Download: Daratumumab, a novel therapeutic human CD38 monoclonal antibody – a promising new treatment option in multiple myeloma

Download this presentation here > The European Antibody Congress  brings together big pharma, big biotech, SME Biotech, academia, regulators and the wider service provider community to discuss the latest R&D and advances in the antibody space – across mAbs, ADCs, bispecifics, multispecifics, and protein scaffolds. At the 2013 event, delegates were fortunate enough to hear from Dr Michael Karl Bauer, Senior Vice President of …